RO 7117997
Alternative Names: RO-7117997Latest Information Update: 21 Dec 2023
At a glance
- Originator Roche
- Developer PsychoGenics
- Class Antiepileptic drugs; Sleep disorder therapies
- Mechanism of Action Equilibrative nucleoside transporter 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Seizures; Sleep disorders